Showing results (21-30 of 89) with videos related to

Sort By:
Pageof 9
BMC Cancer|December 29, 2019
Retrospective cohort study of trifluridine/tipiracil (TAS-102) plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancerDaisuke Kotani, Yasutoshi Kuboki, Satoshi Horasawa, et al.
Cancer Science|January 20, 2025
A Phase I, First-In-Human Study of CBA-1205, an Anti-DLK1 Monoclonal Antibody, in Patients With Advanced Solid TumorsYuki Katsuya, Masafumi Ikeda, Takafumi Koyama, et al.
International Journal of Clinical Oncology|July 2, 2022
Definitive chemoradiotherapy has comparable survival outcomes to esophagectomy in patients with clinical T1N0M0 esophageal squamous cell carcinoma: real-world dataKentaro Sawada, Daisuke Kotani, Hiroki Yukami, et al.
BMJ Supportive & Palliative Care|December 18, 2025
Sedentary time during neoadjuvant chemotherapy in oesophageal cancer: exploratory prospective cohort studyTsuyoshi Harada, Tetsuya Tsuji, Junya Ueno, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 28, 2025
Factors responsible for the decline in physical fitness during neoadjuvant chemotherapy in older patients with esophageal cancer: an exploratory prospective cohort studyTsuyoshi Harada, Tetsuya Tsuji, Junya Ueno, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|November 5, 2024
Clinical mechanism of muscle mass loss during neoadjuvant chemotherapy in older patients with esophageal cancer: a prospective cohort studyTsuyoshi Harada, Tetsuya Tsuji, Junya Ueno, et al.
Gastrointestinal Endoscopy|November 14, 2021
Long-term clinical outcome after endoscopic resection of esophageal squamous cell carcinoma invading the muscularis mucosae without lymphovascular invasionDaiki Sato, Tomohiro Kadota, Atsushi Inaba, et al.
Journal of Cancer Research and Clinical Oncology|October 6, 2022
The area of residual tumor predicts esophageal squamous cell carcinoma prognosis following neoadjuvant chemotherapyMasahiro Adachi, Naoki Aoyama, Motohiro Kojima, et al.
Journal for Immunotherapy of Cancer|February 2, 2019
Clinicopathological and molecular features of responders to nivolumab for patients with advanced gastric cancerSaori Mishima, Akihito Kawazoe, Yoshiaki Nakamura, et al.
International Journal of Clinical Oncology|June 17, 2022
Characteristics and clinical outcomes of patients with advanced gastric or gastroesophageal cancer treated in and out of randomized clinical trials of first-line immune checkpoint inhibitorsYu Aoki, Akihito Kawazoe, Yohei Kubota, et al.
Pageof 9